Coordinate induction of hepatic fatty acyl-CoA oxidase and P4504A1 in rat after activation of the peroxisome proliferator-activated receptor (PPAR) by sulphur-substituted fatty acid analogues

References

• Aarsland A., Aarsaether N., Bremer J., Berge R. K. Alkylthioacetic acid (3-thia fatty acids) as non-β-oxidizable fatty acid analogues: a new group of hypolipidemic drugs. III. Dissociation of cholesterol- and triglyceride-lowering effects and the induction of peroxisomal β-oxidation. Journal of Lipid Research 1989; 30: 1711–1718
   PubMed Web of Science ®Google Scholar
• Aarsland A., Berge R. K. Peroxisome proliferating sulphur- and oxysubstituted fatty acid analogues are activated to acyl coenzyme A thioesters. Biochemical Pharmacology 1991; 41: 53–61
   PubMed Web of Science ®Google Scholar
• Aarsland A., Berge R. K., Bremer J., Aarsaether N. The hypolipidemic peroxisome proliferating drug, bis (carboxymethylthio)-1,10 decane, a dicarboxylic metabolite of tiadenol, is activated to an acylcoenzyme A thioester. Biochimica et Biophysica Acta 1990a; 1033: 176–183
   PubMed Web of Science ®Google Scholar
• Aarsland A., Lundquist M., Borretsen B., Berge R. K. On the effect of peroxisomal β-oxidation and carnitine palmitoyl-transferase activity by eicosapentaenoic acid in liver and heart from rat. Lipids 1990b; 25: 546–548
   PubMed Web of Science ®Google Scholar
• Asiedu D., Aarsland A., Skorve J., Svardal A. M., Berge R. K. Fatty acid metabolism in liver of rats treated with hypolipidemic sulphur-substituted fatty acid analogues. Biochimica et Biophysica Acta 1990; 1044: 211–221
   PubMed Web of Science ®Google Scholar
• Bains S. K., Gardiner S. M., Mannweiler K., Gillett D., Gibson G. G. Immunochemical study on the contribution of hypolipidaemic-induced cytochrome P-452 to the metabolism of lauric acid and arachidonic acid. Biochemical Pharmacology 1985; 34: 3221–3229
   PubMed Web of Science ®Google Scholar
• Bell D. R., Elcombe S. R. Induction of acyl-CoA oxidase and cytochrome P450IVA1 RNA in rat primary hepatocytes culture by peroxisome proliferators. Biochemical Journal 1991; 280: 249–253
   PubMed Web of Science ®Google Scholar
• Berge R. K., Aarsland A., Krvyi H., Aarsaether N., Bremer J. Alkylthioacetic acids (3-thia fatty acids)—a new group of non-β-oxidizable, peroxisome inducing fatty acid analogues. II. Dose—response studies on hepatic peroxisomal and mitochondrial changes and long-chain fatty acid metabolizing enzymes in rat. Biochemical Pharmacology 1989a; 38: 3969–3979
   PubMed Web of Science ®Google Scholar
• Berge R. K., Aarsland A., Kryvi H., Bremer J., Aarsaether N. Alkythioacetic acid (3-thia fatty acids)—a new group of non-β-oxidizable, peroxisome inducing fatty acid analogues. I. A study on the structural requirements for proliferation of peroxisomes and mitochondria in rat liver. Biochimica et Biophysica Acta 1989b; 1004: 345–356
   PubMed Web of Science ®Google Scholar
• Berge R. K., Aarsland A., Osmundsen H., Aarsaether N., Male R. The relationships between the levels of long-chain acyl-CoA and clofibroyl-CoA and the induction of peroxisomal β-oxidation. Peroxisomes in Biology and Medicine, H. D. Fahimi, H. Sies. Springer, Berlin 1987; 273–278
   Google Scholar
• Chatterjee B., Demyan W. F., Lalwani N. D., Reddy J. K., Roy A. K. Reversible alteration of hepatic messenger RNA species for peroxisomal and non-peroxisomal proteins induced by hypolipidaemic drug Wy-14, 643. Biochemical Journal 1983; 214: 879–883
   PubMed Web of Science ®Google Scholar
• Dreyer C., Krey G., Keller H., Givel F., Heftenbein G., Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 1992; 68: 879–887
   PubMed Web of Science ®Google Scholar
• Earnshaw D., Dale J. W., Goldfarb P. S., Gibson G. G. Differential splicing in the 3′ coding region of rat cytochrome P450 (P4504A1) mRNA. FEBS Letters 1988; 235: 357–361
   Google Scholar
• Gibson G. G. Comparative aspects of the mammalian cytochrome P450 IV gene family. Xenobiotica 1989; 19: 1123–1148
   PubMed Web of Science ®Google Scholar
• Gibson G. G., Orton T. C., Tamburini P. P. Cytochrome P-450 induction by clofibrate. Biochemical Journal 1982; 203: 161–168
   PubMed Web of Science ®Google Scholar
• Göttlicher M., Demoz A., Svensson D., Berge R. K., Gustavsson J.-A. Structural and metabolic requirements for activators of the peroxisome proliferator activated receptor (PPAR). Biochemical Pharmacology 1993; 46: 2177–2184
   PubMed Web of Science ®Google Scholar
• Göttlicher M., Widmark E., Li Q., Gustafsson I.-A. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proceedings of the National Academy of Sciences, USA 1992; 89: 4653–4657
   PubMed Web of Science ®Google Scholar
• Hardwick J. P., Song B. J., Huberman E., Gonzales F. J. Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid ω-hydroxylase (cytochrome P450), Identification of a new cytochrome P-450 gene family. Journal of Biological Chemistry 1987; 262: 801–810
   PubMed Web of Science ®Google Scholar
• Hawkins J. M., Jones W. E., Bonner F. W., Gibson G. G. The effects of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. Drug Metabolism Reviews 1987; 18: 441–515
   PubMed Web of Science ®Google Scholar
• Horie S., Suga T. Different regulation of hepatic peroxisomal beta-oxidation activity in rats treated with clonbrate and partially hydrogenated marine oil. Biochemical and Biophysical Research Communications 1990; 166: 780–786
   PubMed Web of Science ®Google Scholar
• Hvattum E., Bergseth S., Pedersen C. N., Bremer J., Aarsland A., Berge K. K. Microsomal oxidation of dodecylthioacetic acid (a 3-thiafatty acid) in rat liver. Biochemical Pharmacology 1991; 41: 945–953
   PubMed Web of Science ®Google Scholar
• Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347: 645–650
   PubMed Web of Science ®Google Scholar
• Lake B. G., Gray T. B. J., Pels Rijcken W. R., Beamand J. A., Gangolli S. D. The effect of hypolipidaemic agents on peroxisomal beta-oxidation and mixed-function oxidase activities in primary cultures of rat hepatocytes. Relationship between induction of palmitoyl-CoA oxidation and lauric acid hydroxylation. Xenobiotica 1984; 14: 269–276
   PubMed Web of Science ®Google Scholar
• Lock E. A., Mitchell A. M., Elcombe C. R. Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annual Reviews in Pharmacology and Toxicology 1989; 29: 145–163
   PubMed Web of Science ®Google Scholar
• Lygre T., Aarsaether N., Stensland E., Aarsland A., Berge R. K. Reparation and measurement of clofibroyl coenzyme A and clofibric acid in rat liver after clofibrate application by reversed-phase high-performance liquid chromatography with photodiode array detection. Journal of Chromatography 1986; 381: 95–105
   PubMed Web of Science ®Google Scholar
• Muerhoff A. S., Griffin K. J., Johnson E. F. The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid co-hydroxylase, by clofibric acid. Journal of Biological Chemistry 1992; 267: 19051–19053
   PubMed Web of Science ®Google Scholar
• Ortiz DE Montellano R., Chan W. K., Tuck S. F., Kaikaus R. M., Bass N. M., Peterson J. A. Mechanism-based probes of the topology and function of fatty acid hydroxylases. FASEB Journal 1992; 6: 695–699
   PubMed Web of Science ®Google Scholar
• Orton T. C., Parker G. L. The effect of hypolipidaemic drugs on the hepatic microsomal drug metabolising enzyme system of the rat: induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid. Drug Metabolism and Disposition 1982; 10: 110–115
   PubMed Web of Science ®Google Scholar
• Reddy J. K., Azarnoff D. L., Hignite C. E. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 1980; 283: 397–398
   PubMed Web of Science ®Google Scholar
• Reddy J. K., Goel S. K., Nemali M. R., Carrino J. J., Laffler T. G., Reddy M. K., Sperbeck S. J., Osumi T., Hashimoto T., Lalwani N., Rao M. S. Transcriptional regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proceedings of the National Academy of Sciences, USA 1986; 83: 1747–1751
   PubMed Web of Science ®Google Scholar
• Sato R., Omura T. Cytochrome P450, T. Omura. Academic, London 1978; 1–23
   Google Scholar
• Sharma R., Lake B. G., Foster J., Gibson G. G. Microsomal cytochrome P-450 induction and peroxisomal proliferation by hypolipidaemic agents in rat liver. Biochemical Pharmacology 1988; 37: 1193–1201
   PubMed Web of Science ®Google Scholar
• Skorve J., Asiedu D. K., Solbakken M., Gjestdal J., Songstad J., Berge R. K. Regulation of fatty acid oxidation and triglyceride and phospholipid metabolism by hypolipidemic sulfur-substituted fatty acid analogues. Biochemical Pharmacology 1990; 43: 815–822
   Google Scholar
• Small G. M., Burdett K., Connock M. J. A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. Biochemical Journal 1985; 227: 205–210
   PubMed Web of Science ®Google Scholar
• Spydevold Ø., Bremer J. Induction of peroxisomal beta-oxidation in 7800 C1 Morris hepatoma cells in steady state by fatty acid analogues. Biochimica et Biophysica Acta 1989; 1003: 72–79
   PubMed Web of Science ®Google Scholar
• Tugwood J. D., Issermann I., Anderson R. G., Bundell K. R., McPheat W. L., Green S. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl-CoA oxidase gene. EMBO Journal 1992; 11: 433–439
   PubMed Web of Science ®Google Scholar